Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 May 15;13(10):2273-9.
doi: 10.1002/j.1460-2075.1994.tb06509.x.

Post-translational alterations in transmembrane topology of the hepatitis B virus large envelope protein

Affiliations

Post-translational alterations in transmembrane topology of the hepatitis B virus large envelope protein

V Bruss et al. EMBO J. .

Abstract

The preS domain at the N-terminus of the large envelope protein (LHBs) of the hepatitis B virus is involved in (i) envelopment of viral nucleocapsids and (ii) binding to the host cell. While the first function suggests a cytosolic location of the preS domain during virion assembly, the function as an attachment site requires its translocation across the lipid bilayer and final exposure on the virion surface. We compared the transmembrane topology of newly synthesized LHBs in the endoplasmic reticulum (ER) membrane with its topology in the envelope of secreted virions. Protease sensitivity and the absence of glycosylation suggest that the entire preS domain of newly synthesized LHBs remains at the cytosolic side of ER vesicles. However, virions secreted from transfected cell cultures or isolated from the blood of persistent virus carriers expose antibody binding sites and proteolytic cleavage sites of the preS domain at their surface in approximately half of the LHBs molecules. Thus, preS domains appear to be transported across the viral lipid barrier by a novel post-translational translocation mechanism to fulfil a dual function in virion assembly and attachment to the host cell.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Virol. 1983 May;46(2):626-8 - PubMed
    1. J Virol. 1991 Jul;65(7):3813-20 - PubMed
    1. J Virol. 1984 Nov;52(2):396-402 - PubMed
    1. Cell. 1986 Aug 1;46(3):429-36 - PubMed
    1. J Exp Med. 1992 Feb 1;175(2):461-9 - PubMed

Publication types

MeSH terms

Substances